← back to search

Ping Gong

Guangzhou University of Chinese Medicine · CN
Area of research
Organic Chemistry · Molecular Biology
Research interest
Research interests include Chemistry, Medicine, Stereochemistry, Programmed cell death, Programmed cell death 1, and Ligand (biochemistry).
h-index
citations
294
works
10
NIH funding
primary concept
email

Recent publications

Clinical analysis of the correlation between food-specific IgG antibody positivity and inflammatory factors in patients with Hashimoto's thyroiditis
Research Square 2026cited by 0position: middledoi
Non-diabetic elderly populations: SIRI as a risk factor and PIV as a protective factor against bone abnormalities
Frontiers in Endocrinology 2024cited by 6position: middledoi
Prediction of early lung adenocarcinoma spread through air spaces by machine learning radiomics: a cross-center cohort study
Translational Lung Cancer Research 2024cited by 6position: middledoi
The real-world study of the clinical characteristics, diagnosis, and treatment of advanced pancreatic cancer in China
Journal of Pancreatology 2023cited by 10position: middledoi
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
Cancer Biology and Medicine 2020cited by 91position: middledoi
Discovery of [1,2,4]Triazolo[4,3-<i>a</i>]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
Journal of Medicinal Chemistry 2019cited by 92position: lastdoi
Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis
European Journal of Medicinal Chemistry 2019cited by 10position: middledoi
Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety
Bioorganic & Medicinal Chemistry Letters 2016cited by 27position: middledoi
Novel hydrazone moiety-bearing aminopyrimidines as selective inhibitors of epidermal growth factor receptor T790M mutant
European Journal of Medicinal Chemistry 2015cited by 17position: middledoi
Design and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents
European Journal of Medicinal Chemistry 2014cited by 35position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Hongbo Xie · Nanchang University4 papers (2014–2019)Mingze Qin · Shenyang Pharmaceutical University3 papers (2014–2019)Yanfang Zhao · University of Alabama at Birmingham2 papers (2015–2019)Nan Jiang · Jinan University2 papers (2015–2019)Qi Cao · China General Nuclear Power Corporation (China)1 papers (2019–2019)Boxuan Xu · Shenyang Pharmaceutical University1 papers (2015–2015)Xin Zhai · Shenyang Pharmaceutical University1 papers (2019–2019)Meng Cao · Nanjing University of Chinese Medicine1 papers (2019–2019)Qian Huang · Xuzhou Medical College1 papers (2024–2024)Xin Zhai · Shenyang Pharmaceutical University1 papers (2016–2016) · 1 papers (2016–2016)Ao Meng · Xuzhou Medical College1 papers (2024–2024)Shuaishuai Zheng · Shenyang Pharmaceutical University1 papers (2019–2019)Chunjiang Wu · University of Electronic Science and Technology of China1 papers (2016–2016)Minglin Zhu · Shenyang Pharmaceutical University1 papers (2019–2019)Xiang Li · Xinxiang Medical University1 papers (2024–2024)Cong Liu · Nanchang University1 papers (2024–2024)Ping Wang · Southwestern Medical Center1 papers (2016–2016)Xiaofeng Li · Xuzhou Medical College1 papers (2024–2024)Yufeng Wang · Nanjing University of Chinese Medicine1 papers (2024–2024)